Northwest Biotherapeutics NWBO
OTC NWBO
$0.15 -0.01 (-6.25%)
At close: Sep 28, 2026 · 4:00 PM EDT

Northwest Biotherapeutics (NWBO) Net Margin (2010 - 2026)

Updated

Northwest Biotherapeutics' Net Margin came in at -1183.77% for Q2 2026, up 10982.65 percentage points from -12166.41% a year earlier but down 495.51 percentage points from the prior quarter.

Analysis

Northwest Biotherapeutics (NWBO) Net Margin (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Northwest Biotherapeutics reported Net Margin of -1789.42%, up 5847.51 percentage points year-over-year; for FY2025, it was -4461.32%, up 1703.08 percentage points from FY2024.

  • Net Margin carries a five-year change of +36578.26 percentage points (FY2020 to FY2025).
  • Going back by year, Net Margin was -6164.40% in FY2024 (-2832.46 pp), -3331.94% in FY2023 (+2908.82 pp), -6240.76% in FY2022 (-24064.24 pp) and 17823.48% in FY2021 (+58863.06 pp).
  • The five-year range for quarterly Net Margin is -15947.57% (Q3 2022) to 186.16% (Q4 2025).
  • Year-over-year, Net Margin has increased for three consecutive quarters, with an average year-over-year change of +512.52 percentage points over the last eight quarters.
  • The fastest year-over-year change in Net Margin over five years came in Q3 2021 (a gain of 86119.26 percentage points), and the weakest in Q3 2022 (a drop of 12207.57 percentage points).
  • Business Quant data shows NWBO's Net Margin at -688.26% (Q1 2026), 186.16% (Q4 2025) and -13591.00% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 21.86%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 21.27%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -8.04%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 22.61%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.81%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 23.62%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -134.51%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 32.99%
10 Northwest Biotherapeutics 250.40 Mn 240.41 Mn - -1,183.77%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,183.77%
Mar 31, 2026 -688.26%
Dec 31, 2025 186.16%
Sep 30, 2025 -13,591.00%
Jun 30, 2025 -12,166.41%
Mar 31, 2025 -5,228.80%
Dec 31, 2024 -12,335.93%
Sep 30, 2024 -5,463.87%
Jun 30, 2024 -3,590.20%
Mar 31, 2024 -6,647.89%
Dec 31, 2023 -3,217.53%
Sep 30, 2023 -5,921.43%
Jun 30, 2023 -7,446.27%
Mar 31, 2023 -1,255.34%
Dec 31, 2022 -4,740.03%
Sep 30, 2022 -15,947.57%
Jun 30, 2022 -6,219.71%
Mar 31, 2022 -3,527.05%
Sep 30, 2021 -3,740.00%
Jun 30, 2021 -3,146.63%
API Access

Northwest Biotherapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=NWBO&period=max&api_key=YOUR_API_KEY